C291H297Br2F5N43O18S+ — CID 160697594
2-(5-bromopyrimidin-2-yl)-1-cyclopentyl-3-methyl-N-[1-[1-methyl-6-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]indole-5-carboxamide;2-(5-bromopyrimidin-2-yl)-3-(4,4-difluorocyclohexyl)-1-methyl-N-[1-[1-methyl-6-(2-methylpyrimidin-5-yl)benzimidazol-2-yl]cyclobutyl]indole-6-carboxamide;1-cyclohexyl-2-(5-fluoropyrimidin-2-yl)-3-methyl-N-[1-[1-methyl-6-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclopent-3-en-1-yl]indole-5-carboxamide;1-cyclohexyl-3-methyl-N-[1-[1-methyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-thiophen-3-ylindole-5-carboxamide;3-cyclopentyl-2-(furan-3-yl)-1-methyl-N-[1-[1-methyl-5-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclopent-3-en-1-yl]indole-6-carboxamide;1-cyclopentyl-3-methyl-N-[1-[1-methyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-(2-oxo-1H-pyridin-3-yl)indole-5-carboxamide;3-cyclopentyl-1-methyl-N-[1-[1-methyl-5-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-pyrazin-2-ylindole-6-carboxamide;3-(3,3-difluorocyclopentyl)-N-[1-[1,1-dimethyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-1-ium-2-yl]cyclobutyl]-2-(furan-3-yl)-1-methylindole-6-carboxamide (PubChem CID 160697594) has the molecular formula C291H297Br2F5N43O18S+ and a molecular weight of 4971.73 g/mol. Its IUPAC name is 2-(5-bromopyrimidin-2-yl)-1-cyclopentyl-3-methyl-N-[1-[1-methyl-6-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]indole-5-carboxamide;2-(5-bromopyrimidin-2-yl)-3-(4,4-difluorocyclohexyl)-1-methyl-N-[1-[1-methyl-6-(2-methylpyrimidin-5-yl)benzimidazol-2-yl]cyclobutyl]indole-6-carboxamide;1-cyclohexyl-2-(5-fluoropyrimidin-2-yl)-3-methyl-N-[1-[1-methyl-6-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclopent-3-en-1-yl]indole-5-carboxamide;1-cyclohexyl-3-methyl-N-[1-[1-methyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-thiophen-3-ylindole-5-carboxamide;3-cyclopentyl-2-(furan-3-yl)-1-methyl-N-[1-[1-methyl-5-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclopent-3-en-1-yl]indole-6-carboxamide;1-cyclopentyl-3-methyl-N-[1-[1-methyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-(2-oxo-1H-pyridin-3-yl)indole-5-carboxamide;3-cyclopentyl-1-methyl-N-[1-[1-methyl-5-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-pyrazin-2-ylindole-6-carboxamide;3-(3,3-difluorocyclopentyl)-N-[1-[1,1-dimethyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-1-ium-2-yl]cyclobutyl]-2-(furan-3-yl)-1-methylindole-6-carboxamide.
| Compound Name | 2-(5-bromopyrimidin-2-yl)-1-cyclopentyl-3-methyl-N-[1-[1-methyl-6-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]indole-5-carboxamide;2-(5-bromopyrimidin-2-yl)-3-(4,4-difluorocyclohexyl)-1-methyl-N-[1-[1-methyl-6-(2-methylpyrimidin-5-yl)benzimidazol-2-yl]cyclobutyl]indole-6-carboxamide;1-cyclohexyl-2-(5-fluoropyrimidin-2-yl)-3-methyl-N-[1-[1-methyl-6-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclopent-3-en-1-yl]indole-5-carboxamide;1-cyclohexyl-3-methyl-N-[1-[1-methyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-thiophen-3-ylindole-5-carboxamide;3-cyclopentyl-2-(furan-3-yl)-1-methyl-N-[1-[1-methyl-5-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclopent-3-en-1-yl]indole-6-carboxamide;1-cyclopentyl-3-methyl-N-[1-[1-methyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-(2-oxo-1H-pyridin-3-yl)indole-5-carboxamide;3-cyclopentyl-1-methyl-N-[1-[1-methyl-5-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-pyrazin-2-ylindole-6-carboxamide;3-(3,3-difluorocyclopentyl)-N-[1-[1,1-dimethyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-1-ium-2-yl]cyclobutyl]-2-(furan-3-yl)-1-methylindole-6-carboxamide |
|---|---|
| PubChem CID | 160697594 |
| Molecular Formula | C291H297Br2F5N43O18S+ |
| Molecular Weight | 4971.73 g/mol |
| Exact Mass | 4966.16 |
| IUPAC Name | 2-(5-bromopyrimidin-2-yl)-1-cyclopentyl-3-methyl-N-[1-[1-methyl-6-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]indole-5-carboxamide;2-(5-bromopyrimidin-2-yl)-3-(4,4-difluorocyclohexyl)-1-methyl-N-[1-[1-methyl-6-(2-methylpyrimidin-5-yl)benzimidazol-2-yl]cyclobutyl]indole-6-carboxamide;1-cyclohexyl-2-(5-fluoropyrimidin-2-yl)-3-methyl-N-[1-[1-methyl-6-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclopent-3-en-1-yl]indole-5-carboxamide;1-cyclohexyl-3-methyl-N-[1-[1-methyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-thiophen-3-ylindole-5-carboxamide;3-cyclopentyl-2-(furan-3-yl)-1-methyl-N-[1-[1-methyl-5-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclopent-3-en-1-yl]indole-6-carboxamide;1-cyclopentyl-3-methyl-N-[1-[1-methyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-(2-oxo-1H-pyridin-3-yl)indole-5-carboxamide;3-cyclopentyl-1-methyl-N-[1-[1-methyl-5-[(E)-3-oxobut-1-enyl]benzimidazol-2-yl]cyclobutyl]-2-pyrazin-2-ylindole-6-carboxamide;3-(3,3-difluorocyclopentyl)-N-[1-[1,1-dimethyl-6-[(E)-2-methyl-3-oxobut-1-enyl]benzimidazol-1-ium-2-yl]cyclobutyl]-2-(furan-3-yl)-1-methylindole-6-carboxamide |
| SMILES | CC(=O)/C(C)=C/c1ccc2c(c1)[N+](C)(C)C(C1(NC(=O)c3ccc4c(C5CCC(F)(F)C5)c(-c5ccoc5)n(C)c4c3)CCC1)=N2.CC(=O)/C(C)=C/c1ccc2nc(C3(NC(=O)c4ccc5c(c4)c(C)c(-c4ccc[nH]c4=O)n5C4CCCC4)CCC3)n(C)c2c1.CC(=O)/C(C)=C/c1ccc2nc(C3(NC(=O)c4ccc5c(c4)c(C)c(-c4ccsc4)n5C4CCCCC4)CCC3)n(C)c2c1.CC(=O)/C=C/c1ccc2c(c1)nc(C1(NC(=O)c3ccc4c(C5CCCC5)c(-c5ccoc5)n(C)c4c3)CC=CC1)n2C.CC(=O)/C=C/c1ccc2c(c1)nc(C1(NC(=O)c3ccc4c(C5CCCC5)c(-c5cnccn5)n(C)c4c3)CCC1)n2C.CC(=O)/C=C/c1ccc2nc(C3(NC(=O)c4ccc5c(c4)c(C)c(-c4ncc(Br)cn4)n5C4CCCC4)CCC3)n(C)c2c1.CC(=O)/C=C/c1ccc2nc(C3(NC(=O)c4ccc5c(c4)c(C)c(-c4ncc(F)cn4)n5C4CCCCC4)CC=CC3)n(C)c2c1.Cc1ncc(-c2ccc3nc(C4(NC(=O)c5ccc6c(C7CCC(F)(F)CC7)c(-c7ncc(Br)cn7)n(C)c6c5)CCC4)n(C)c3c2)cn1 |
| InChI | InChI=1S/C37H35BrF2N8O.C37H38F2N4O3.C37H37FN6O2.C37H39N5O3.C37H40N4O2S.C36H36N4O3.C35H35BrN6O2.C35H36N6O2/c1-21-41-17-25(18-42-21)23-6-8-28-30(15-23)48(3)35(45-28)36(11-4-12-36)46-34(49)24-5-7-27-29(16-24)47(2)32(33-43-19-26(38)20-44-33)31(27)22-9-13-37(39,40)14-10-22;1-22(23(2)44)17-24-7-10-29-31(18-24)43(4,5)35(40-29)36(13-6-14-36)41-34(45)25-8-9-28-30(19-25)42(3)33(27-12-16-46-21-27)32(28)26-11-15-37(38,39)20-26;1-23(45)11-12-25-13-15-30-32(19-25)43(3)36(41-30)37(17-7-8-18-37)42-35(46)26-14-16-31-29(20-26)24(2)33(34-39-21-27(38)22-40-34)44(31)28-9-5-4-6-10-28;1-22(24(3)43)19-25-12-14-30-32(20-25)41(4)36(39-30)37(16-8-17-37)40-34(44)26-13-15-31-29(21-26)23(2)33(28-11-7-18-38-35(28)45)42(31)27-9-5-6-10-27;1-23(25(3)42)19-26-11-13-31-33(20-26)40(4)36(38-31)37(16-8-17-37)39-35(43)27-12-14-32-30(21-27)24(2)34(28-15-18-44-22-28)41(32)29-9-6-5-7-10-29;1-23(41)10-11-24-12-15-30-29(20-24)37-35(40(30)3)36(17-6-7-18-36)38-34(42)26-13-14-28-31(21-26)39(2)33(27-16-19-43-22-27)32(28)25-8-4-5-9-25;1-21(43)9-10-23-11-13-28-30(17-23)41(3)34(39-28)35(15-6-16-35)40-33(44)24-12-14-29-27(18-24)22(2)31(32-37-19-25(36)20-38-32)42(29)26-7-4-5-8-26;1-22(42)9-10-23-11-14-29-27(19-23)38-34(41(29)3)35(15-6-16-35)39-33(43)25-12-13-26-30(20-25)40(2)32(28-21-36-17-18-37-28)31(26)24-7-4-5-8-24/h5-8,15-20,22H,4,9-14H2,1-3H3,(H,46,49);7-10,12,16-19,21,26H,6,11,13-15,20H2,1-5H3;7-8,11-16,19-22,28H,4-6,9-10,17-18H2,1-3H3,(H,42,46);7,11-15,18-21,27H,5-6,8-10,16-17H2,1-4H3,(H,38,45)(H,40,44);11-15,18-22,29H,5-10,16-17H2,1-4H3,(H,39,43);6-7,10-16,19-22,25H,4-5,8-9,17-18H2,1-3H3,(H,38,42);9-14,17-20,26H,4-8,15-16H2,1-3H3,(H,40,44);9-14,17-21,24H,4-8,15-16H2,1-3H3,(H,39,43)/p+1/b;22-17+;12-11+;22-19+;23-19+;11-10+;2*10-9+ |
| InChIKey | WOYFTHIFGSIOJG-LFSYOQOFSA-O |
| XLogP | 61.68 |
| TPSA | 716.87 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 52 |
| Rotatable Bonds | 55 |
| Heavy Atoms | 360 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4971.73 |
| LogP ≤ 5 | 61.68 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 52 |